2007•Unpublished venueRequires access

Study on clinical pharmacokinetics of tegaserod hydrogen maleate tablet in healthy Chinese volunteers by LC-MS

Dongsheng Ouyang

Open publisher page 0 citations

Abstract

AIM:To study the pharmacokineties of Te- gaserod Hydrogen Maleate Tablet in healthy Chinese vol- unteers.METHODS:The volunteers received a single 6,12 or 18 mg dose of tegaserod orally,respectively.Te- gaserod in plasma was determined by LC-MS.RE- SULTS:The pharmacokinetics of tegaserod conformed to a 2-compartment open model after single oral dose(6,12 and 18 nag).The t_(max)was(2.2±1.0),(1.3±0.5), (1.3±0.4)h;C_(max)was(3.4±0.4),(8.5±1.4), (12.0±2.4)ng/mL;t1/2αwas(5.5±6.4),(4.6±5.6),(2.0±2.0)h;t1/2βwas(16.2±2.4),(15.2±1.8),(14.9±2.0)h;AUC_(0→48)was(53±9),(96±29),(135±54)ng·h·mL~(-1);AUC_(0→∞)was(64±12), (108±33),(158±60)ng·h·mL~(-1);MRTwas(16.3±1.0),(14.8±1.1),(14.6±0.7)h.The C_(max) AUC_(0→48)and AUC_(0→∞)were correlated linearly with dos- age within 6-18 mg.The statistical analysis indicated that the t_(max),t1/2α,t1/2βand MRT had no significant dif- ferences among different groups.The plasma concentration of tegaserod reached steadv state after successive adminis- tration of 3 clays,and the t_(max),C_(ss,max),C_(ss,max),C_(ss,max), DF were(1.5±0.4)h,(8.1±1.3),(2.6±0.7), (4.4±0.8)ng/mL,(126±16)% respectively.The C_(max),AUC_(0→48),AUC_(0→∞)and t1/2βwere apparently more than those reported in other population.CONCLUSION: The pharmacokinetics of tegaserod hydrogen maleate tablet in healthy chinese volunteers can be described by a two compartment model and has a linear dynamics character within the range of 6-18 mg.

About this research paper

What this paper is about

AIM:To study the pharmacokineties of Te- gaserod Hydrogen Maleate Tablet in healthy Chinese vol- unteers.METHODS:The volunteers received a single 6,12 or 18 mg dose of tegaserod orally,respectively.Te- gaserod in plasma was determined by LC-MS.RE- SULTS:The pharmacokinetics of tegaserod conformed to a 2-compartment open model after single oral dose(6,12 and 18 nag).The t_(max)was(2.2±1.0),(1.3±0.5), (1.3±0.4)h;C_(max)was(3.4±0.4),(8.5±1.4), (12.0±2.4)ng/mL;t1/2αwas(5.5±6.4),(4.6±5.6),(2.0±2.0)h;t1/2βwas(16.2±2.4),(15.2±1.8),(14.9±2.0)h;AUC_(0→48)was(53±9),(96±29),(135±54)ng·h·mL~(-1);AUC_(0→∞)was(64±12), (108±33),(158±60)ng·h·mL~(-1);MRTwas(16.3±1.0),(14.8±1.1),(14.6±0.7)h.The C_(max) AUC_(0→48)and AUC_(0→∞)were correlated linearly with dos- age within 6-18 mg.The statistical analysis indicated that the t_(max),t1/2α,t1/2βand MRT had no significant dif- ferences among different groups.The plasma concentration of tegaserod reached steadv state after successive adminis- tration of 3 clays,and the t_(max),C_(ss,max),C_(ss,max),C_(ss,max), DF were(1.5±0.4)h,(8.1±1.3),(2.6±0.7), (4.4±0.8)ng/mL,(126±16)% respectively.The C_(max),AUC_(0→48),AUC_(0→∞)and t1/2βwere apparently more than those reported in other population.CONCLUSION: The pharmacokinetics of tegaserod hydrogen maleate tablet in healthy chinese volunteers can be described by a two compartment model and has a linear dynamics character within the range of 6-18 mg.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To study the pharmacokineties of Te- gaserod Hydrogen Maleate Tablet in healthy Chinese vol- unteers.METHODS:The volunteers received a single 6,12 or 18 mg dose of tegaserod orally,respectively.Te- gaserod in plasma was determined by LC-MS.RE- SULTS:The pharmacokinetics of tegaserod conformed to a 2-compartment open model after single oral dose(6,12 and 18 nag).The t_(max)was(2.2±1.0),(1.3±0.5), (1.3±0.4)h;C_(max)was(3.4±0.4),(8.5±1.4), (12.0±2.4)ng/mL;t1/2αwas(5.5±6.4),(4.6±5.6),(2.0±2.0)h;t1/2βwas(16.2±2.4),(15.2±1.8),(14.9±2.0)h;AUC_(0→48)was(53±9),(96±29),(135±54)ng·h·mL~(-1);AUC_(0→∞)was(64±12), (108±33),(158±60)ng·h·mL~(-1);MRTwas(16.3±1.0),(14.8±1.1),(14.6±0.7)h.The C_(max) AUC_(0→48)and AUC_(0→∞)were correlated linearly with dos- age within 6-18 mg.The statistical analysis indicated that the t_(max),t1/2α,t1/2βand MRT had no significant dif- ferences among different groups.The plasma concentration of tegaserod reached steadv state after successive adminis- tration of 3 clays,and the t_(max),C_(ss,max),C_(ss,max),C_(ss,max), DF were(1.5±0.4)h,(8.1±1.3),(2.6±0.7), (4.4±0.8)ng/mL,(126±16)% respectively.The C_(max),AUC_(0→48),AUC_(0→∞)and t1/2βwere apparently more than those reported in other population.CONCLUSION: The pharmacokinetics of tegaserod hydrogen maleate tablet in healthy chinese volunteers can be described by a two compartment model and has a linear dynamics character within the range of 6-18 mg.

Key concepts: Pharmacokinetics, Tegaserod, Chemistry, Plasma concentration, Pharmacology, Medicine, Internal medicine, Irritable bowel syndrome

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on clinical pharmacokinetics of tegaserod hydrogen maleate tablet in healthy Chinese volunteers by LC-MS — Research Paper | ScholarLens